Recent insights into nanotechnology development for detection and treatment of colorectal cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Viswanath, Buddolla | - |
dc.contributor.author | Kim, Sanghyo | - |
dc.contributor.author | Lee, Kiyoung | - |
dc.date.available | 2020-02-28T06:43:48Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 1178-2013 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/9725 | - |
dc.description.abstract | The global incidence of colorectal cancer (CRC) is 1.3 million cases. It is the third most frequent cancer in males and females. Most CRCs are adenocarcinomas and often begin as a polyp on the inner wall of the rectum or colon. Some of these polyps become malignant, eventually. Detecting and removing these polyps in time can prevent CRC. Therefore, early diagnosis of CRC is advantageous for preventive and instant action interventions to decrease the mortality rates. Nanotechnology has been enhancing different methods for the detection and treatment of CRCs, and the research has provided hope within the scientific community for the development of new therapeutic strategies. This review presents the recent development of nanotechnology for the detection and treatment of CRC. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | DOVE MEDICAL PRESS LTD | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF NANOMEDICINE | - |
dc.subject | CIRCULATING TUMOR-CELLS | - |
dc.subject | GROWTH-FACTOR RECEPTOR | - |
dc.subject | COLON-CANCER | - |
dc.subject | CHITOSAN NANOPARTICLES | - |
dc.subject | PLGA NANOPARTICLES | - |
dc.subject | PERIPHERAL-BLOOD | - |
dc.subject | DRUG-DELIVERY | - |
dc.subject | QUANTUM DOTS | - |
dc.subject | CURCUMIN | - |
dc.subject | DENDRIMERS | - |
dc.title | Recent insights into nanotechnology development for detection and treatment of colorectal cancer | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000377086400001 | - |
dc.identifier.doi | 10.2147/IJN.S108715 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF NANOMEDICINE, v.11, pp.2491 - 2504 | - |
dc.identifier.scopusid | 2-s2.0-84971572019 | - |
dc.citation.endPage | 2504 | - |
dc.citation.startPage | 2491 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF NANOMEDICINE | - |
dc.citation.volume | 11 | - |
dc.contributor.affiliatedAuthor | Viswanath, Buddolla | - |
dc.contributor.affiliatedAuthor | Kim, Sanghyo | - |
dc.contributor.affiliatedAuthor | Lee, Kiyoung | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | colorectal cancer | - |
dc.subject.keywordAuthor | nanotechnology | - |
dc.subject.keywordAuthor | detection | - |
dc.subject.keywordAuthor | treatment | - |
dc.subject.keywordAuthor | targeted therapy | - |
dc.subject.keywordPlus | CIRCULATING TUMOR-CELLS | - |
dc.subject.keywordPlus | GROWTH-FACTOR RECEPTOR | - |
dc.subject.keywordPlus | COLON-CANCER | - |
dc.subject.keywordPlus | CHITOSAN NANOPARTICLES | - |
dc.subject.keywordPlus | PLGA NANOPARTICLES | - |
dc.subject.keywordPlus | PERIPHERAL-BLOOD | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | QUANTUM DOTS | - |
dc.subject.keywordPlus | CURCUMIN | - |
dc.subject.keywordPlus | DENDRIMERS | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Nanoscience & Nanotechnology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.